[-] Show simple item record

dc.contributor.authorHernandez, Rickeng
dc.contributor.authorEdgerton, Lisaeng
dc.contributor.authorFlake, Donnaeng
dc.date.issued2008eng
dc.description.abstractArthralgias and myalgias have been observed clinically in children and adolescents exposed to fluoroquinolones, but they're transient, disappear when the drug is discontinued, and appear to be no more prevalent than with other antibiotics (strength of recommendation [SOR]: B, 1 structured review and 2 prospective cohort studies). No apparent long-term risk of developmental skeletal growth delay is associated with fluoroquinolone exposure (SOR: B, 1 prospective controlled study).eng
dc.identifier.urihttp://hdl.handle.net/10355/3792eng
dc.languageEnglisheng
dc.publisherFamily Physicians Inquiries Networkeng
dc.relation.ispartofcollectionClinical Inquiries, 2008 (MU)eng
dc.relation.ispartofcommunityUniversity of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Networkeng
dc.relation.ispartofseriesJournal of family practice, 57, no. 08 (August 2008): 539-540.eng
dc.rightsOpenAccess.eng
dc.rights.licenseThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.eng
dc.subjectarthralgiaeng
dc.subjectskeletal growtheng
dc.subjecttendon ruptureeng
dc.subjectdrug resistanceeng
dc.subject.lcshAntibacterial agents -- Side effectseng
dc.subject.lcshQuinolone antibacterial agents -- Side effectseng
dc.subject.lcshInfection in children -- Treatmenteng
dc.titleIs there much risk in using fluoroquinolones in children?eng
dc.typeArticleeng


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record